Literature DB >> 19531611

NICE wobbles.

Alan Maynard, Karen Bloor.   

Abstract

Mesh：

Year:  2009        PMID： 19531611      PMCID： PMC2697044          DOI： 10.1258/jrsm.2009.09k031

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

2.  Value based pricing for NHS drugs: an opportunity not to be missed?

Authors:  Karl Claxton; Andrew Briggs; Martin J Buxton; Anthony J Culyer; Christopher McCabe; Simon Walker; Mark J Sculpher
Journal:  BMJ       Date:  2008-02-02

3.  Should NICE's threshold range for cost per QALY be raised? Yes.

Authors:  Adrian Towse
Journal:  BMJ       Date:  2009-01-26

4.  Should NICE's threshold range for cost per QALY be raised? No.

Authors:  James Raftery
Journal:  BMJ       Date:  2009-01-26

5.  The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.

Authors:  Mark Pickin; Cindy L Cooper; Timothy Chater; Anthony O'Hagan; Keith R Abrams; Nicola J Cooper; Mike Boggild; Jackie Palace; George Ebers; James B Chilcott; Paul Tappenden; Jon Nicholl
Journal:  BMC Neurol       Date:  2009-01-06       Impact factor: 2.474
  5 in total
  1 in total

1.  Drugs, money and society (Part II).

Authors:  Tom Walley
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.